As of 2026-03-29, the Fair Value of Enzymatica AB (publ) (ENZY.ST) is -1.07 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.49 SEK, the upside of Enzymatica AB (publ) is -142.93%.
With the market price of 2.49 SEK and our fair value calculation, Enzymatica AB (publ) (ENZY.ST) is not a good investment. Investing in ENZY.ST stocks now will result in a potential loss of 142.93%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -45.39 | -68.66 | -49.73 | -53.18 | -51.89 | -53.77 |
| YoY growth | -243.34% | -51.25% | 27.57% | -6.94% | 2.42% | -54.31% |
| Market Cap (mil) | 604.42 |
| P/E | |
| Forward P/E |
| EPS | -0.21 |
| Avg earnings growth rate | -54.31% |
| TTM earnings | -51.89 |